HeartSciences (HSCS) Competitors $4.16 -1.57 (-27.40%) Closing price 04:00 PM EasternExtended Trading$4.28 +0.12 (+2.88%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PSTV, IRIX, XAIR, MHUA, DHAI, LYRA, INBS, PAVM, WOK, and IINNShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Plus Therapeutics (PSTV), IRIDEX (IRIX), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), DIH Holding US (DHAI), Lyra Therapeutics (LYRA), Intelligent Bio Solutions (INBS), PAVmed (PAVM), WORK Medical Technology Group (WOK), and Inspira Technologies OXY B.H.N. (IINN). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Plus Therapeutics IRIDEX Beyond Air Meihua International Medical Technologies DIH Holding US Lyra Therapeutics Intelligent Bio Solutions PAVmed WORK Medical Technology Group Inspira Technologies OXY B.H.N. Plus Therapeutics (NASDAQ:PSTV) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Does the media refer more to PSTV or HSCS? In the previous week, Plus Therapeutics had 2 more articles in the media than HeartSciences. MarketBeat recorded 4 mentions for Plus Therapeutics and 2 mentions for HeartSciences. HeartSciences' average media sentiment score of 0.94 beat Plus Therapeutics' score of 0.00 indicating that HeartSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Plus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of PSTV or HSCS? 3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 3.8% of Plus Therapeutics shares are owned by insiders. Comparatively, 1.8% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher valuation & earnings, PSTV or HSCS? HeartSciences has lower revenue, but higher earnings than Plus Therapeutics. HeartSciences is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPlus Therapeutics$5.82M3.15-$12.98M-$2.94-0.12HeartSciencesN/AN/A-$6.61M-$7.48-0.56 Do analysts prefer PSTV or HSCS? Plus Therapeutics presently has a consensus target price of $10.83, indicating a potential upside of 2,911.77%. HeartSciences has a consensus target price of $13.00, indicating a potential upside of 212.50%. Given Plus Therapeutics' higher possible upside, equities analysts plainly believe Plus Therapeutics is more favorable than HeartSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Plus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PSTV or HSCS more profitable? HeartSciences has a net margin of 0.00% compared to Plus Therapeutics' net margin of -520.90%. Plus Therapeutics' return on equity of 0.00% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets Plus Therapeutics-520.90% N/A -202.73% HeartSciences N/A -178.80%-109.28% Which has more risk and volatility, PSTV or HSCS? Plus Therapeutics has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, meaning that its share price is 157% more volatile than the S&P 500. SummaryPlus Therapeutics and HeartSciences tied by winning 7 of the 14 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.50M$1.95B$5.52B$9.07BDividend YieldN/AN/A5.25%4.02%P/E Ratio-0.5634.5627.7220.26Price / SalesN/A11.48367.0678.98Price / CashN/A56.5937.4258.29Price / Book0.378.368.045.49Net Income-$6.61M-$62.39M$3.18B$250.27M7 Day Performance13.20%5.08%3.72%4.78%1 Month Performance12.13%7.81%3.72%7.20%1 Year Performance2.97%6.83%29.92%17.27% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences2.4652 of 5 stars$4.16-27.4%$13.00+212.5%+29.6%$4.50MN/A-0.5610Gap UpHigh Trading VolumePSTVPlus Therapeutics1.7256 of 5 stars$0.31-10.8%$10.83+3,393.5%-81.5%$15.81MN/A-0.1120IRIXIRIDEX1.1378 of 5 stars$0.89+0.9%N/A-48.5%$14.95M$48.67M-2.07120XAIRBeyond Air4.6172 of 5 stars$0.17+0.4%$1.50+767.1%-67.3%$14.94M$3.71M-0.2270News CoveragePositive NewsGap DownMHUAMeihua International Medical Technologies1.2313 of 5 stars$0.42+4.5%N/A-50.4%$13.33M$96.90M0.00620Positive NewsDHAIDIH Holding US0.162 of 5 stars$0.25+3.1%N/A-92.4%$11.96M$64.47M-0.84N/AGap DownLYRALyra Therapeutics1.8859 of 5 stars$8.90-0.7%$100.00+1,023.6%-38.1%$11.84M$1.53M-0.1550INBSIntelligent Bio Solutions0.4147 of 5 stars$1.68-2.3%N/A+1.1%$11.61M$3.11M0.0010PAVMPAVmed4.42 of 5 stars$0.62+2.6%$19.00+2,983.9%-25.9%$10.53M$2.99M0.8790Positive NewsWOKWORK Medical Technology GroupN/A$0.71+2.9%N/AN/A$10.36M$11.51M0.00226Gap DownIINNInspira Technologies OXY B.H.N.2.4779 of 5 stars$0.81-4.3%$2.00+145.8%+5.8%$10.27MN/A0.0020News CoverageAnalyst RevisionGap Down Related Companies and Tools Related Companies Plus Therapeutics Competitors IRIDEX Competitors Beyond Air Competitors Meihua International Medical Technologies Competitors DIH Holding US Competitors Lyra Therapeutics Competitors Intelligent Bio Solutions Competitors PAVmed Competitors WORK Medical Technology Group Competitors Inspira Technologies OXY B.H.N. Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSCS Stock Alerts